Showing 961 - 980 results of 10,612 for search '"real life"', query time: 0.24s Refine Results
  1. 961

    Treatment adherence and effect of concurrent statin intensity on the efficacy and safety of alirocumab in a real-life setting: results from ODYSSEY APPRISE by Maciej Banach, José Luis López-Sendon, Maurizio Averna, Bertrand Cariou, Megan Loy, Garen Manvelian, Isabela Batsu, Yann Poulouin, Daniel Gaudet

    Published 2021-10-01
    “…Treatment-emergent adverse events occurred in 65.2–75.1% and 68.0–76.3% of patients across statin and ezetimibe subgroups, respectively. Conclusions In a real-life setting, patient adherence to alirocumab was high. …”
    Get full text
    Article
  2. 962
  3. 963
  4. 964

    Control of Low-Density Lipoprotein Cholesterol in Secondary Prevention of Coronary Artery Disease in Real-Life Practice: The DAUSSET Study in French Cardiologists by Jean Ferrières, François Roubille, Michel Farnier, Patrick Jourdain, Denis Angoulvant, Franck Boccara, Nicolas Danchin

    Published 2021-12-01
    “…It aimed to describe real-life clinical practices for low-density lipoprotein (LDL) cholesterol control in the secondary prevention of CAD. …”
    Get full text
    Article
  5. 965
  6. 966
  7. 967

    The Use of HSQoL-24 in an Assessment of Quality-of-Life Impairment among Hidradenitis Suppurativa Patients: First Look at Real-Life Data by Piotr K. Krajewski, Servando E. Marrón, Manuel Gomez-Barrera, Lucía Tomas-Aragones, Yolanda Gilaberte-Calzada, Jacek C. Szepietowski

    Published 2021-11-01
    “…The study shows that the HSQoL-24 questionnaire is a reliable, HS-specific tool for measuring the QoL among patients with HS in real-life clinical settings.…”
    Get full text
    Article
  8. 968

    Evolution of the Therapeutic Management of Giant Cell Arteritis: Analysis of Real-Life Practices over Two Timeframes (2014–2017 and 2018–2020) by Hubert de Boysson, Anael Dumont, Paul Castan, Sophie Gallou, Jonathan Boutemy, Gwénola Maigné, Nicolas Martin Silva, Alexandre Nguyen, Samuel Deshayes, Achille Aouba

    Published 2023-11-01
    “…<b>Conclusions:</b> This real-life study showed a global change in GC management over time for GCA patients, with important variability among physicians’ practices.…”
    Get full text
    Article
  9. 969
  10. 970

    Real-life effectiveness of transitioning from paliperidone palmitate 1-monthly to paliperidone palmitate 3-monthly long-acting injectable formulation by Olivier Corbeil, Anne-Marie Essiambre, Laurent Béchard, Audrey-Anne Roy, Maxime Huot-Lavoie, Sébastien Brodeur, Ranjith Chandrasena, Chantale Thériault, Candice Crocker, Jean-Pierre Melun, Phil Tibbo, Marie-France Demers, Marc-André Roy

    Published 2022-11-01
    “…Randomized clinical trials (RCTs) have demonstrated the efficacy of paliperidone palmitate 3-monthly (PP3M) for psychotic relapse prevention in schizophrenia, but it remains poorly documented among individuals treated in real-life settings who can benefit the most out of LAIs. …”
    Get full text
    Article
  11. 971
  12. 972
  13. 973
  14. 974
  15. 975
  16. 976
  17. 977
  18. 978

    Patterns of the physical, cognitive, and mental health status of older individuals in a real-life primary care setting and differences in coping styles by Thomas Wittlinger, Sanja Bekić, Sanja Bekić, Silva Guljaš, Vlatka Periša, Mile Volarić, Ljiljana Trtica Majnarić, Ljiljana Trtica Majnarić

    Published 2022-10-01
    “…Mental health disorders, anxiety and depression, are common in older people with multimorbidity, in particular those with functional or sensory deficits, and frailty.PurposeThe aim of this study was to show how physical frailty, cognitive impairments and mental disorders, cluster in the real life setting of older primary care (PC) patients, and how these clusters relate to age, comorbidities, stressful events, and coping strategies. …”
    Get full text
    Article
  19. 979
  20. 980